Transcode Therapeutics Inc. (RNAZ)
Market Closed
16 Jun, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
5. 54
+0.07
+1.2797%
After Hours
$
+0.56 +10.1083% 6. 10
5.07M Market Cap
- P/E Ratio
- Div Yield
11,912 Volume
-2.14 Eps
$ 5.47
Previous Close Analysts:
Want to track RNAZ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Transcode Therapeutics Inc. (RNAZ) Statistics
Valuation metrics
Market Cap 5.07M
Enterprise value -7.77M
Trailing P/E (ttm) -0.12
Forward P/E -
PEG ratio -0
Price/Sales (ttm) -
Price/Book (mrq) 0.03
Enterprise Value/Revenue -
Enterprise Value/EBITDA 0.26
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 336.89K
Average volume (90 days) 50.11K
Price summary
52-Week low 3.82
52-Week high 20.99
Beta -
50-Day moving average 6.5
200-Day moving average 8.36
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -42.75
Dividend Date -
Ex-Dividend Date -
Last split factor 1:28
Last split Date 15 May 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.26%
Return on equity -0.99%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -44.02
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 14
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 3.11%
Book value per share (mrq) 157.61
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
